Immuron Ltd (IMRN)

Add to Watchlists
Create an Alert
3.66 -1.37  -27.24% NASDAQ May 24, 20:00 Delayed 2m USD
View Full Chart
IMRN Price Chart
View All Events

IMRN Events

Date Type Description
02/28/2019 Earnings Immuron Ltd Second Quarter Earnings Results in 2019
11/19/2018 Misc Immuron Ltd Annual General Meeting in 2018
09/27/2018 Misc Immuron Ltd Annual Report in 2018
View All Performance Charts

IMRN Total Returns Comparison


IMRN One Page Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: Feb. 28, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company‚Äôs lead product candidate, IMM-124E, is a proprietary immunomodulator agent targeted at GI immune-mediated diseases including fatty-liver diseases.

IMRN Comparables


Excel Add-In Codes

  • Name: =YCI("IMRN","name")
  • Description: =YCI("IMRN","description")
  • Sector: =YCI("IMRN","sector")
  • Industry: =YCI("IMRN","industry")
  • Est. Current Fiscal Year End: =YCI("IMRN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.